On Saturday, many of those impacted gathered at Cascades park to march for funding and awareness in the Walk to End Alzheimer’s. Tallahassee resident and walk participant Phyllis Leonard lost her ...

JC Watt shares his story on why he started this fundraiser for Alzheimer's and its new location at the Star Centre in Havre ...

Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era ...

If you’ve ever watched Shark Tank, you probably know Barbara Corcoran. On the show, she invests in businesses, but away from ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug ...

Cassava Sciences (NASDAQ:SAVA) said Tuesday it will shut down its Alzheimer's disease program by the end of the second quarter after another Phase 3 trial failure for simufilam, its lead ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

At the end of that study, researchers allowed participants who ... His relatives who carry the mutation begin showing ...

Optimising medication to enhance comfort and quality of life for people with dementia nearing the end of their life. This is a Self-assessment article and comes with a self-assessment test NT ...

While Cassava is stopping investigations into simufilam in Alzheimer’s disease, the therapy is now being evaluated in ...

Now, he joins the Alzheimer’s Association 24-member volunteer governing board in steering the strategic direction of the organization as it carries out its mission to end Alzheimer’s and all ...